Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The European clinical diagnostics market – Germany and France

This article was originally published in Clinica

Executive Summary

Germany and France are the number-one and -two markets in Europe for clinical diagnostics products, respectively, each with their own unique characteristics and challenges.

You may also be interested in...

The clinical diagnostics market – the rest of the world

Sales in the clinical diagnostics market in the rest of world region, which in this analysis includes China and India, totalled $5.4bn in 2010. The market is forecast to grow at 9.9% per year over the 2010-2015 interval. In the ROW region, growth will be driven by rapid adoption of new technologies and increasing utilisation of healthcare resources in developing countries in Asia (particularly China and India) and, to a lesser extent, in Latin America.

The European clinical diagnostics market – Italy and the UK

Italy is the third-largest clinical diagnostics country market in Europe, with a total market size only slightly smaller than that of France. Italy devoted 9.6% of its gross domestic product (GDP) to healthcare expenditures in 2010, up from 8.7% in 2007, according to statistics from the Organization for Economic Cooperation and Development. This is higher than in the late 1990s and early 2000s, although spending as a percentage of GDP dropped as low as 7.4% in 1995, similar to rates in the UK and Spain.

Japan: the world's No 2 clinical diagnostics market

The clinical diagnostics market in Japan has begun to exhibit moderate growth after an extended period of stagnation linked to the dormant Japanese economy. The volume of clinical diagnostic tests performed in Japan declined at single-digit rates in the early 2000s, including decreases in sales of immunodiagnostic tests. Growth in the Japanese clinical diagnostics market is still projected to be slow relative to the overall global market but, based on recent sales figures from Japanese suppliers, has recovered substantially and will approach the rate forecast for the US over the 2010-2015 period. In spite of its slow growth, Japan is the second-largest country market worldwide for clinical diagnostics products after the US, and accounts for over 10% of the global market.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts